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CBFA2 and CBFB are frequently involved in chromo-§Department of Pathology
somal translocations in acute leukemia (Miyoshi et al.,Tufts University Schools of Medicine
1991; Liu et al., 1993). Cbfa2 is widely expressed inand Veterinary Medicine
mouse embryo and adult tissues (Simeone et al., 1995;Boston, Massachusetts 02111
Satake et al., 1995), and Cbfb expression is ubiquitous‖First Department of Anatomy
(Ogawa et al., 1993b; Wang et al., 1993; Satake et al.,Osaka City University Medical School
1995). The heterodimerization of Cbfa2 and Cbfb is re-1±4±54 Asahimachi, Abeno-ku
quired for their DNA-binding capacity in vitro (Ogawa etOsaka, 545, Japan
al., 1993b; Wang et al., 1993). The targeted disruption of
Cbfa2 resulted in the embryonic death at midgestation,
owing to hemorrhage in the central nervous system,Summary
and blocked fetal liver hematopoiesis. The phenotype
of Cbfb-deficient mice (Sasaki et al., 1996; Wang etA transcription factor, Cbfa1, which belongs to the
al., 1996a) was similar to that of Cbfa2-deficient micerunt-domain gene family, is expressed restrictively in
(Okuda et al., 1996; Wang et al., 1996b). Therefore, itfetal development. To elucidate the function of Cbfa1,
was confirmed that Cbfb is essential for the function of
we generated mice with a mutated Cbfa1 locus. Mice
Cbfa2 in vivo. As Cbfb is also necessary for the DNA
with a homozygous mutation in Cbfa1 died just after
binding of Cbfa1 in vitro (Ogawa et al., 1993a), it wasbirth without breathing. Examination of their skeletal
suggested that Cbfa2 is the earliest gene necessarysystems showed a complete lack of ossification. Al-
for embryogenesis among the runt-domain gene family
though immature osteoblasts, which expressed alka-
(Sasaki et al., 1996; Wang et al., 1996a).
line phophatase weakly but not Osteopontin and Os-
In contrast, the expression of Cbfa1 seemed to be
teocalcin, and a few immature osteoclasts appeared
restricted. It was detected in T cell lines and NIH3T3
at the perichondrial region, neither vascular nor mes- cells but not in B cell lines (Ogawa et al., 1993a). It was
enchymal cell invasion was observed in the cartilage. also detected in thymus and testis but not in the tissues
Therefore, our data suggest that both intramembra- including brain, lung, heart, spleen, liver, and kidney
nous and endochondral ossification were completely (Satake et al., 1995). Consistent with these observations,
blocked, owing to the maturational arrest of osteo- there is a Cbf site in the regulatory regions of many T
blasts in the mutant mice, and demonstrate that Cbfa1 cell-specific genes, including the T cell receptor a, b, g,
plays an essential role in osteogenesis. and d genes, and Cbfa1 binds to T cell receptor b en-
hancer and stimulates the enhancer activity in vitro
Introduction (Ogawa et al., 1993a). These observations led to the
speculation that Cbfa1 is likely to be involved in T lym-
Cbfa1 (core-binding factor), also called Pebp2aA (poly- phocyte-specific transcriptional regulation (Satake et
oma enhancer-binding protein), is a transcription factor al., 1995). However, the function of Cbfa1 in vivo remains
that belongs to the runt-domain gene family. Three runt- to be clarified.
domain genes (Cbfa1/Pebp2aA, Cbfa2/Pebp2aB, and The skeletal tissue is composed of various types of
Cbfa3/Pebp2aC) have been identified (Bae et al., 1993, mesenchymal cells, among which are osteoblasts,
1995; Ogawa et al., 1993a). They have a DNA binding chondrocytes, myoblasts, and bone-marrow stromal
domain, runt, which is homologous with the Drosophila cells, including adipocytes. These cell lineages are be-
pair-rule gene runt (Kania et al., 1990), and they form lieved to originate from common mesenchymal progeni-
heterodimers with cotranscription factor Cbfb/Pebp2b tors (Aubin et al., 1993). These progenitors acquire
and acquire enhanced DNA-binding capacity in vitro specific phenotypes depending on the maturational
(Ogawa et al., 1993b; Wang et al., 1993). Cbf specifically stage of the particular cell type during the differentiation
recognizes a consensus sequence, PuACCPuCA, which process. In the case of skeletal muscles, the muscle-
specific transcription factors of the MyoD family, whichwas originally identified in the polyoma virus enhancer
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belong to the basic Helix-Loop-Helix family, are neces-
sary for determining the pathway of differentiation into
the muscle lineage and are required for the differentia-
tion from a determined myoblast to a fully differentiated
myotube (Weintraub, 1993). In addition, peroxisomepro-
liferator-activated receptor g2 (PPARg2) plays an impor-
tant role in determining the pathway of differentiation
into the adipocyte lineage (Tontonoz et al., 1994). How-
ever, the specific transcription factors that are neces-
sary for differentiation into the osteoblast lineage and
the maturation of osteoblasts have not been clarified.
Identification of these factors is necessary in order to
understand the molecular mechanism involved in osteo-
blast differentiation and skeletogenesis.
To elucidate the function of Cbfa1, we generated mu-
tated mice in which the Cbfa1 gene locus was targeted.
The mutated mice died just after birth and showed
a complete lack of bone formation. Although the devel-
opment of cartilage was nearly normal, ossification was
completely blocked throughout thebody. Here,we show
that Cbfa1 is essential for the maturation of osteoblasts
Figure 1. Generation of Mutant Miceand both intramembranous and endochondral ossifi-
cation. (A) Structure of the targeting vector and partial restriction map of
genomic Cbfa1 locus and mutated allele after homologous recombi-
nation. Exon 1 is depicted as a hatched box, and PGK-neo and
PGK-tk as closed boxes. B, BamHI; Cl, ClaI; Bg, BglII; Bst, BstEII;Results
N, NotI. ClaI, BglII, and BstEII sites between 39 ClaI and BamHI sites
have not been determined.
Immediate Postnatal Death of Cbfa1-Deficient Mice (B) Southern blot analysis of fetal DNA. Genomic DNA isolated from
To disrupt the Cbfa1 gene, 1.2 kb of exon 1, which livers of embryos was digested with BamHI and hybridized with the
contains the first 41 amino acids of the runt domain, ClaI-SalI* probe shown in (A) (asterisk denotes the site in the cloning
vector). Bands are indicated corresponding to wild type (12.5 kb)was replaced with PGK-neo (Figure 1A). The target-
and mutant (9.5 kb) genes.ing vector was electroporated into the E14 line of
(C) RT±PCR analysis of runt region of Cbfa1. Total RNA was isolatedembryonic stem (ES) cells and selected by G418 and
from livers of wild type (1/1), heterozygous (1/2), and mutant (2/2)
gancyclovir. Targeted ES cells were injected into blasto- embryos at d18.5. N, no cDNA in the reaction mixture of PCR.
cysts of C57BL/6 mice. The chimeras were mated with
C57BL/6 mice, and the Cbfa1 mutation was transmitted
through the germline. The heterozygous (Cbfa11/2) mice is essential for DNA binding and heterodimerization with
Cbfb, the function of Cbfa1 should have been abolishedresembled normal mice in gross appearance. In addi-
tion, their body weight was not significantly different in homozygous embryos.
from that of wild-type mice at four weeks of age (1/2,
18.6 6 3.4 g; 1/1, 20.8 6 2.6 g in male. 1/2, 16.7 6 Absence of Ossification in Cbfa12/2 Mice
Since mutant (Cbfa12/2) embryos and newborns uni-2.9 g; 1/1, 17.0 6 2.7 g in female), and they were fertile.
After intercrossing of heterozygous mice, no homozy- formly showed dwarfism and had short legs, embryos
and newborns were examined by soft X-ray and doublegous (Cbfa12/2) mice were observed in our analysis of
the genotype of 4-week-old litters (data not shown). stained by Alizarin red and Alcian blue to evaluate the
development of skeletal systems (Figures 2B and 2C).However, a few newborns were found dead in every
litter, and their genotype was always Cbfa12/2. At em- Soft X-rayexamination of the wild-type embryos atd18.5
revealed that various skeletal components including thebryonic day 18.5 (d18.5), however, we found live homo-
zygous embryos at the frequency predicted by Mende- skull, mandibula, upper and lower extremities, ribs, and
vertebrate were well calcified. In mutant embryos atlian law (Figure 1B; data not shown). After intercrossing
heterozygous mice, we observed their delivery and no- d18.5, however, parts of the tibia, radius, and vertebrae
were weakly calcified, and no calcification was found inticed that small newborns scarcely breathed and soon
died; all of these mice were homozygous. It was ascer- the skull, mandibula, humerus, and femur. Furthermore,
Alizarin red staining of mutant embryos at d15.5±d16.5tained that they were alive just after delivery because
they reacted to stimulation for severalminutes; however, showed an absence of calcification throughout the
body, unlike wild-type embryos, which exhibited well-they soon became cyanotic. The weight of homozygous
embryos at d18.5 was approximately 80% of that of calcified skeletons. Calcification stained by Alizarin red
increased from d15.5 to birth in wild-type mice. In con-heterozygous and wild-type embryos (1/1, 1.16 6 0.21
g; 1/2, 1.17 6 0.14 g; 2/2, 0.93 6 0.22 g), and they trast, weak staining by Alizarin red was observed in the
tibia, fibula, radius, and ulna, and pinpoint staining inhad short legs (Figure 2A). To confirm that the Cbfa1
gene was disrupted, we carried out RT±PCR of the runt the dorsal arch of vertebrae and the dorsal part of ribs of
d17.5±18.5 mutant embryos and newborns. Conversely,domain (Figure 1C). Homozygous embryos lacked am-
plified cDNA of the runt region. Since the runt domain the development of cartilage in mutant mice seemed to
Lack of Bone Formation in Cbfa1-Deficient Mice
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Figure 2. Examination of Skeletal System
(A) Gross appearance of wild type (1/1), het-
erozygous (1/2), and mutant (2/2) embryos
at d18.5. Mutant embryo is small and has
short legs. Bar 5 1 cm.
(B) X-ray of d18.5 wild type and mutant em-
bryo. Mutant embryo has a barely calcified
skeleton.
(C) The skeleton from d15.5±d18.5 embryos
and newborns of wild type, heterozygous,
and homozygous genotype. Embryos and
newborns were double stained with Alizarin
redand Alcian blue except for d16.5 embryos,
which were stained with only Alizarin red.
Bar 5 1 cm.
be normal upon staining with Alcian blue. Heterozygous number of nuclei were reduced in comparison with those
in wild-type embryos (Figures 3J and 3I). Femurs of(Cbfa11/2) embryos and newborns showed no signifi-
cant abnormality in skeletal development except for mutant embryos were composed of noncalcified carti-
lage, and neither ALP-positive nor TRAP-positive cellsclavicles and cranium (Figure 2C). They exhibited hypo-
plastic clavicles and nasal bones and retarded ossifica- appeared at perichondrium of the femurs (data not
shown).tion of parietal, interparietal, and supraoccipital bones.
Histological sections of skeleton from d18.5 embryos Well-calcified bones were formed between brain and
subcutaneous connective tissue at the calvaria of d18.5were examined by staining with alkaline phosphatase
(ALP), von Kossa's method, and tartrate-resistant acid wild-type embryos (Figure 3K). The bone surface was
covered with numerous ALP-positive osteoblasts (Fig-phosphatase (TRAP) (Figure 3). In d18.5 wild-type em-
bryos, tibiae consisted of three parts: two cartilaginous ure 3M). Several TRAP-positive osteoclasts were also
observed on the bone surface (data not shown). In d18.5epiphysis at the proximal and distal ends and a bony
diaphysis in the middle (Figure 3A). In the diaphysis, mutant embryos, only a thin layer of fibrous connective
tissue was observed between the brain and subcutane-well-calcified bones were observed in the cortical and
metaphysial regions (Figure 3C). These calcified bones ous connective tissue (Figure 3L). ALP-positive cells
were detected in the fibrous connective tissues, butwere surroundedby numerous ALP-positive osteoblasts
(Figure 3E). Many TRAP-positive osteoclasts were scat- no calcified bone was observed (Figure 3N). No TRAP-
positive cells were found in the calvarial region of mutanttered on the surface of calcified bones and cartilage
(Figure 3G). A large bone-marrow cavity was formed at embryos (data not shown).
the middle of the diaphysis (Figure 3A). In d18.5 mutant
embryos, the middle part of tibia remained as calcified Preferential Expression of Cbfa1 in Osteoblasts
To examine the expression of Cbfa1, sections fromcartilage without formation of the bone-marrow cavity
(Figures 3B and 3D). Neither vascular nor mesenchymal d18.5 wild-type embryos were hybridized with an RNA
probe of Cbfa1, and skeletons were positively stainedcell invasion was observed in the calcified cartilage.
Although ALP-positive cells appeared in the perichon- (Figures 4A±4D). In the skeleton, osteoblasts expressed
Cbfa1 more strongly than chondrocytes (Figure 4C),drial region of the calcified cartilage, no bone was
formed (Figures 3D and 3F). A few TRAP-positive cells whereas osteoclasts did not show significant Cbfa1 ex-
pression (Figures 4C and 4D; data not shown). Althoughappeared adjacent to the calcified cartilage at the peri-
chondrium (Figure 3H), but the size of the cells and the thymocytes expressed Cbfa1 (Figure 4E) as previously
Cell
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Figure 3. Histological Analysis of Skeleton of
d18.5 Embryos
(A and B) Total view of tibia stained with ALP
and von Kossa's method. Wild-type embryo
(1/1) (A) shows the generation of bone mar-
row, which is lacking in mutant embryo (2/2)
(B). Bar 5 1 mm.
(C and D) Ossification and ALP-positive os-
teoblasts are seen in diaphysis of wild-type
embryo (C). Mutant embryo shows calcified
cartilage without subperiosteal ossification.
Note that ALP-positive cells are observed at
perichondrial region, but no invasion of ALP-
positive cells into cartilage (D). Cells stained
blue represent ALP-positive cells, and matri-
ces stained black represent calcified matri-
ces. Higher magnification of boxed region of
(A) and (B). Bar 5 0.2 mm.
(E and F) Cuboidal ALP-positive osteoblasts
on the trabecular bone surface in the bone
marrow (E) and flat ALP-positive osteoblasts
at perichondrial region of mutant embryo (F).
Note that mutant embryo shows no ossifica-
tion at all. Higher magnification of boxed
region of (C) and (D). Bar 5 20 mm.
(G and H) Tibia stained by TRAP and von
Kossa's method. Many TRAP-positive osteo-
clasts on calcified bone surface of wild-type
embryo (G). Note a few TRAP-positive osteo-
clasts around the calcified cartilage, but no
invasion of these cells into cartilage (H).
Cells stained red represent TRAP-positive
cells, and matrices stained black represent
calcified matrices. Bar 5 0.2 mm.
(I and J) Large mutinucleated osteoclasts in
the bone marrow of wild-type embryo (I)
and small mononuclear osteoclasts around
cartilage of mutant embryo (J). Higher magni-
fication of boxed region of (G) and (H). Bar 5
20 mm.
(K and L) Calvaria from wild type (K) and
mutant (L) embryos were stained by ALP
and von Kossa's method. Cells stained blue
represent ALP-positive cells, and matrices
stained black represent calcified matrices.
Bar 5 0.2 mm.
(M and N) Ossification andcuboidal ALP-pos-
itive osteoblasts in wild-type embryo (M) and
flat ALP-positive osteoblasts without ossifi-
cation in mutant embryo (N). Note that cal-
varia of mutant embryo is composed of only
a thin layer of osteoblasts. Bar 5 20 mm.
described (Satake et al., 1995), there were no abnormal deposits of mineral in the vascular walls of the placenta
in mutant embryos (data not shown). mRNA of Cbfa1findings in the thymus of mutant embryos histologically
(data not shown). Development of ab T cells and gd T was detectable in livers by RT±PCR (Figure 1C), but we
did not detect Cbfa1 expression by in situ hybridizationcells was normal in the thymus by FACS analysis, al-
though the number of thymocytes was significantly in tissues including brain, heart, lung, gut, liver, and
muscle of d18.5 wild-type embryos; there were no ab-fewer in mutant embryos than in wild type and heterozy-
gous embryos (data not shown). Cbfa1 was also ex- normal findings histologically in these tissues of mutant
embryos (data not shown).pressed in tendon and weakly in dermis (Figures 4F and
4G), but a histological study of the tendon showed no Furthermore, we examined Cbfa1 expression in devel-
oping limbs from d10.5±14.5 wild-type embryos. Untildifference between wild type and mutant embryos (data
not shown). In dermis, Cbfa1 was expressed in fibro- d12.5, we observed only faint signal from developing
limbs, with no significant localization. Significant Cbfa1blasts. Although fibroblasts in the dermis of mutant
embryos seemed to be slightly fewer in number than expression was first detected in the region surrounding
cartilaginous condensation and in the tendon from d13.5those in the dermis of wild-type embryos, the thickness
of the dermis was similar (data not shown). embryos. Cbfa1 expression was more evident in the
perichondrial region and tendon of limbs from d14.5Although we did not detect significant Cbfa1 expres-
sion in placenta, we found dilated blood vessels and embryos (data not shown).
Lack of Bone Formation in Cbfa1-Deficient Mice
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Figure 4. Spatial Expression of Cbfa1
(A and B) In situ hybridization of d18.5 wild-
type embryos with Cbfa1 antisense (A) and
sense (B) probe. The pretreatment by protein-
ase K for in situ hybridization was done for
25 min for the analysis of skeleton and 10 min
for the analysis of thymus. The pretreatment
by proteinase K for 25 min reduced the signal
from thymus.
(C and D) In situ hybridization of radius (C)
and calvaria (D) of d18.5 wild-type embryos
with Cbfa1 antisense probe.
(E±G) In situ hybridization of thymus (E), ten-
don (F), andwhiskers follicle (G) of d18.5 wild-
type embryo with Cbfa1 antisense probe.
Bar 5 0.5 cm in (A) and (B); 0.1 mm in (C),
(D), (F), and (G); and 0.2 mm in (E).
Expression of Noncollagenous Bone-Matrix Proteins of rhBMP-2 induced Osteocalcin in both groups; how-
Sections from control (1/2) and mutant (2/2) embryos ever, the Osteocalcin produced by mutant embryos was
at d18.5 were hybridized by RNA probes of noncollage- about one-third of that produced by wild type and het-
nous bone-matrix proteins including Osteonectin, Os- erozygous embryos (Figure 6C).
teopontin, Osteocalcin, and Matrix Gla Protein (MGP) to
determine the maturational stage of osteoblasts and
chondrocytes (Figure 5). The osteoblasts in control em- Discussion
bryos were hybridized by Osteonectin, Osteopontin, and
Osteocalcin (Figures 5C, 5E, and 5G). The osteoblasts The Cbfa12/2 newborns died without breathing. The in-
in mutant mice, which were flat shaped and observed jection of glucose had no effect, and the expression of
only in the perichondrial region, were hybridized by Os- surfactant proteins was normal (data not shown). Fur-
teonectin (Figure 5D), but were only weakly hybridized thermore, we detected no abnormalities in the central
by Osteopontin and not at all by Osteocalcin (Figures nervous system of mutant mice. The absence of ossifi-
5F and 5H). Chondrocytes in both control and mutant cation of the ribs is considered to be a major cause
embryos were stained by Osteonectin and MGP (Figures of the lack of breathing and, moreover, of their death.
5C, 5D, 5I, and 5J). However, hypertrophied chondro- Ribs lacking in ossification would not be strong enough
cytes in mutant embryos expressed Osteopontin at to provide the negative pressure needed for lung
barely detectable levels, while expression was more in- expansion.
tense in control embryos (Figures 5F and 5E). Since Cbfa12/2 embryos exhibited the complete lack
The expression of ALP, Osteopontin, and Osteocalcin of bone formation, we examined the expression of Os-
was examined by Northern blot analysis using RNA from teonectin, ALP, Osteopontin, and Osteocalcin for the
the skeleton (Figure 6A). Whereas wild-type embryos determination of maturational stage of osteoblasts. Os-
expressed all three, mutant embryos expressed ALP teonectin is a secreted phosphorylated calcium-binding
weakly, Osteopontin barely, and Osteocalcin not at all, glycoprotein that binds to type I collagen, and it is de-
findings that were consistent with the data from in situ
tected from early osteoprogenitor cells to osteocytes
hybridization (Figure 5).
(Ibaraki et al., 1992; Hirakawa et al., 1994). Osteopontin
is a sialic acid-rich phosphorylated glycoprotein. Osteo-Differentiation of Osteoblasts In Vitro
calcin, a calcium-binding protein also knownas the boneThe effects of recombinant human BMP-2 (rhBMP-2)
Gla protein (BGP), is a vitamin K-dependent protein thaton ALP activity and Osteocalcin production in calvaria-
can bind hydroxyapatite. ALP expression and Osteo-derived cells were compared between the mix-culture
pontin expression appear in differentiating osteoblasticof wild type and heterozygous embryos and the culture
cells before the expression of Osteocalcin, and all threeof mutant embryos. Exposure to rhBMP-2 for three days
are downregulated in the late mineralization phaseincreased ALP activity in both cultures, but the activity
(Bronkers et al., 1987; Weinreb et al., 1990; Ibaraki etin culture of mutant embryos was about one-third of
al., 1992; Stein and Lian, 1993; Malaval et al., 1994).that in the mix-culture of wild type and heterozygous
Osteoblasts show increased ALP expression as theyembryos (data not shown). Prolonged culture for another
mature before mineralization phase (Rodan et al., 1988).three days in the presence of rhBMP-2 increased the
Osteoblasts of mutant mice expressed Osteonectin, aALP activity in culture of mutant embryos to more than
low level of ALP, and barely detectable amounts of Os-half that in mix-culture of wild type and heterozygous
teopontin and Osteocalcin (Figures 3, 5, and 6A). Theseembryos (Figure 6B). Although culture in the presence
data indicate that the maturational arrest occurs at anof rhBMP-2 for three days did not increase the produc-
early stage of osteoblast differentiation in Cbfa12/2 em-tion of Osteocalcin in either group (data not shown),
prolonged culture for another three days in the presence bryos.
Cell
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Figure 6. Expression of Maturational Markers for Osteoblasts
(A) Northern blot hybridized with ALP, Osteopontin (OSP), and Os-
Figure 5. Distribution of Osteonectin, Osteopontin, Osteocalcin, teocalcin (OSC) probes. RNA was extracted from skeleton of d18.5
and MGP mRNA control (1/2) and mutant (2/2) embryos, and 15 mg of total RNA
(A, C, E, G, and I) Radius from d18.5 control (1/2) embryo. (B, D, was loaded per lane. The filter hybridized with ALP probe was rehy-
F, H, and J) Radius from d18.5 mutant (2/2) embryo. (A and B) bridized with Osteopontin probe. Hybridization with the GAPDH
Staining with hematoxylin and eosin. (C and D) In situ hybridization probe was used as internal control for the loading of even amount
by Osteonectin antisense probe. (E and F) Osteopontin antisense of RNA for analysis.
probe. (G and H) Osteocalcin antisense probe. (I and J) MGP anti- (B and C) Effect of rhBMP-2 on ALP activity (B) and production of
sense probe. Bar 5 0.15 mm. Osteocalcin (C) in calvaria-derived cells isolated from wild type,
heterozygous,and mutant embryos at d18.5. The cells obtained from
wild type and heterozygous mice were combined and are shown byCbfa1 expression was restricted throughout fetal de-
open bars, and the cells obtained from mutant mice are shown by
velopment (Figure 4; data not shown). We first detected closed bars. ALP activity and concentration of Osteocalcin were
significant expression of Cbfa1 in the region surrounding examined after culture for six days with various concentrations of
cartilaginous condensation and in the tendon of d13.5 rhBMP-2.
embryos. Thereafter, Cbfa1 expression was evident in
the perichondrial region and tendon. However, signifi-
in BMP-2-induced Osteocalcin synthesis, at least in incant Cbfa1 expression was not seen in the undifferenti-
vitro culture. Indeed, the down-regulation of Osteocalcinated mesenchymal cells of d12.5 embryos. Furthermore,
cannot explain the complete lack of osteogenesis ofCbfa12/2 embryos expressed ALP and Osteonectin,
Cbfa12/2 mice, because knockout mice for theOsteocal-which are early markers of osteoblasts, in the perichon-
cin gene showed increased bone formation (Ducy et al.,drial region. Therefore, Cbfa1 seems to play an essential
1996).role in the differentiation of immature osteoblasts that
The expression of Osteonectin, MGP, and Osteopon-have been directed toward the osteoblastic lineage.
tin were also examined as markers of the differentiationOsteocalcin, the promoter region of which has three
of chondrocytes. Osteonectin is also expressed in chon-Cbf sites and binds to Cbf-related protein (Geoffroy et
drocytes (Nomura et al., 1988; Copray et al., 1989; Chenal., 1995; Merriman et al., 1995; Banerjee et al., 1996),
et al., 1991). MGP is a Gla-containing vitamin K-depen-may be one of the target genes of Cbfa1. Although cal-
dent protein and has been detected in chondrocytes invaria-derived cells isolated from Cbfa12/2 embryos
embryonic and adult bones (Hale et al., 1988; Ikeda etshowed less production of Osteocalcin than that from
al., 1992). Osteopontin has been detected not only incontrol in response to rhBMP-2, the increase of Osteo-
osteoblasts but also in hypertrophied chondrocytescalcin synthesis was observed in the cells from mutant
(Mark et al., 1988; Nomura et al., 1988; Franzen et al.,embryos at high dose rhBMP-2. This suggests that tran-
scription factors other than Cbfa1 play important roles 1989; Chen et al., 1991). Chondrocytes of both mutant
Lack of Bone Formation in Cbfa1-Deficient Mice
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and wild-type embryos expressed Osteonectin and Heterozygous (Cbfa11/2) embryos exhibited hypo-
MGP (Figure 5). However, in contrast to our findings in plastic clavicles and nasal bones, and retarded ossifica-
wild-type embryos, we did not detect significant Osteo- tion of parietal, interparietal, and supraoccipital bones.
pontin expression in the hypertrophied chondrocytes of Heterozygous adult mice also had prominent hypoplasia
mutant embryos (Figure 5F). Furthermore, the calcifica- of clavicles, although its degree was varied among the
tion normally seen in the region of finally differentiated mice from a tiny ossification center at the acromial end
hypertrophied chondrocytes was observed in restricted to thin clavicle with normal length (unpublished data).
parts of the cartilage of mutant embryos (Figures 2C These skeletal changes are similar to that of cleidocra-
and 3; data not shown). These data suggest that the nial dysplasia, which is a dominantly inherited disease
final differentiation of chondrocytes is also impaired in (Jarvis and Keats, 1974). A microdeletion in chromo-
mutant embryos. some 6p21 has been shown in one family with cleidocra-
In the present study, a few osteoclasts were observed nial dysplasia (Mundlos et al., 1995). Furthermore, a radi-
around calcified cartilage in mutant mice, but they were ation-induced mutant mouse that carries similarities
small and mononuclear, indicating a lack of maturation with cleidocranial dysplasia has been reported to have
(Figures 3H and 3J). Since we did not detect Cbfa1 the deletion in chromosome 17 distal to MHC in an area
expression in osteoclasts (Figures 4C and 4D; data not that shows homology to human 6p (Mundlos et al.,1996).
shown), it is unlikely that the lack of osteoclast matura- Since human CBFA1 was mapped to chromosome 6p21
tion is caused by osteoclasts themselves. The differenti- (Levanon et al., 1994), it is suggested that CBFA1 is the
ation of osteoclasts is regulated by multiple factors pro- gene that causes cleidocranial dysplasia.
duced by other cells. Among these factors is M-CSF, Finally, our data demonstrate that the Cbfa1 is essen-
which is produced mainly by osteoblasts and bone- tial for osteogenesis, especially for the development of
marrow stromal cells (Kodama et al., 1991a; Tanaka et osteoblasts. However, the mechanisms by which the
al., 1993). The levels of M-CSF mRNA expression, as maturation of osteoblasts and osteoclasts is arrested
assessed by RT±PCR using mRNA both from skeleton need to be further clarified. The requirements for vascu-
and calvaria-derived cells, were almost the same in wild lar invasion into cartilage also has to be investigated.
type and mutant embryos (data not shown). This sug- And most importantly, the target genes regulated by
gests that M-CSF is not an essential factor in the lack Cbfa1 have to be clarified. Cbfa1 may regulate several
of osteoclast differentiation. The contact of osteoclast
genes, including Osteopontin, Osteocalcin, and some
progenitors with osteogenic cells, including bone-mar-
other known and unknown genes. Further examination
row stromal cells, is requisite for osteoclast differentia-
of the mutant mice will elucidate these issues.
tion (Takahashi et al., 1988; Kodama et al., 1991b). It is
possible that the maturational arrest of osteoblasts is a
Experimental Procedures
major cause of the absence of osteoclast differentiation,
but further studies are necessary to demonstrate this. Construction of Targeting Vector
During the development of long bones in mammals, We screened the 129/Sv mouse genomic library in the Lambda Fix
II phage vector (Stratagene) with cDNA of the runt domain of Cbfa2.subperiosteal bone is formed around calcified cartilage
After making a restriction map and carrying out sequencing, webefore the formation of bone marrow. Osteogenic cells
obtained genomic fragments containing the runt domain of Cbfa1,and blood capillaries then invade from the periosteal
Cbfa2, and Cbfa3, respectively. The fragment that contained theregion into the calcified cartilage to form endochondral
first exon of Cbfa1 was used for disruption of the Cbfa1 gene. To
bone and the bone-marrow cavity. In the case of construct targeting vector, a 2.3 kb genomic ClaI±BglII fragment
Cbfa12/2 embryos, however, no subperiosteal bone was was cloned into a ClaI±BamHI site of pBluescript SK (Stratagene)
formed around the calcified cartilage of the tibia and that contained PGK-HSV-tk at its SspI site. An EcoRI±BglII fragment
that contained PGK-neo was blunt-end ligated into a blunt-endedradius. The insufficient bone formation in this region
XbaI site. To obtain the final targeting vector, a 1.3 kb genomicin Cbfa12/2 embryos might have caused the lack of
BstEII±ClaI fragment was blunt-end ligated into a blunt-ended NotIsubsequent endochondral ossification and bone-marrow
site, and an 11.2 kb genomic SalI*±ClaI fragment was inserted into
formation. Alternatively, it is possible that insufficient a SalI±ClaI site of pBluescript SK that contained a 2.3 kb genomic
differentiation of chondrocytes affects the differentia- ClaI±BglII fragment, PGK-HSV-tk, and PGK-neo (asterisk denotes a
tion of osteoblasts and osteoclasts. The down-regula- site in cloning vector).
tion of Osteopontin in hypertrophied chondrocytes of
Generation of Mutant MiceCbfa12/2 embryos may be one of the causes of the
Culture, selection of ES cells, and screening of targeted clones wereinability of osteoblasts and osteoclasts to invade the
carried out as described (Komori et al., 1993). Selected clones werecartilage, because Osteopontin has the putative Cbf
screened by Southern blot analysis of BamHI-digested genomicbinding sites in the 59 flanking region (Miyazaki et al.,
DNA probed with the ClaI±SalI fragment (SalI site is a site in the
1990), and it is thought to promote the attachment of cloning vector). The mutated ES clone was injected into blastocysts
osteoblasts and osteoclasts to the extracellular matrix of C57BL/6J and transferred into uteri of pseudopregnant ICR fe-
(Somerman et al., 1987; Reinholt et al., 1990; Miyauchi males. The resulting chimeric animals were backcrossed to C57BL/
6J, and heterozygous mutants were identified by genomic Southernet al., 1991). In contrast to endochondral ossification,
blotting tail-tip DNA. Brother±sister mating was then carried out tointramembranous ossification directly forms bones
generate homozygous mutants.without cartilage formation. In the calvaria of Cbfa12/2
embryos, complete blockage of intramembranous ossi-
RT±PCR
fication accompanied the maturational arrest of osteo- cDNA, which was made from total RNA of livers, was amplified by
blasts. Taken together, these findings indicate that the Amp Taq DNA polymerase (Perkin Elmer) using the following prim-
maturational block of osteoblasts is one of the primary ers: Cbfa1, 59-CCGCACGACAACCGCACCAT-39 and 59-CGCTCCG
GCCCACAAATCTC-39; HPRT, 59-GCTGGTGAAAAGGACCTCT-39causes of complete lack of osteogenesis.
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and 59-CACAGGACTAGAACACCTGC-39. Thirty cycles of amplifica- released was estimated by measuring absorbance at 410 nm. Pro-
tein concentration was determined using a BCA protein assay kittion were done with a Gene Amp PCR system 2400 (Perkin Elmer)
(30 s at 948C, 30 s at 608C or 508C, and 30 s at 728C). (Pierce Chemical Co., Rockford, IL). Amounts of Osteocalcin se-
creted into the culture medium during the last 3 day culture were
measured by RIA using a mouse Osteocalcin assay kit (BiomedicalX-Ray Examination and Skeletal Preparation
Technologies Inc., Stoughton, MA).Radiograms of the wild type and mutant mice were taken by soft
X-rays (type SRO-M50, SOFRON, Tokyo, Japan). Embryos from
Acknowledgmentsd15.5±d18.5 and newborn mice were eviscerated and fixed in 100%
ethanol for 4 days and transferred to acetone. After 3 days, they
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